Sikarin PCL (BKK:SKR-R) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:SKR-R Sikarin PCL BKK:SKR-R
90 GF Score
Price ฿7.85
GF Value ฿8.11
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Sikarin PCL 5-Year Yield-on-Cost %?

Sikarin PCL BKK:SKR-R -0.63% 90 5-Year Yield-on-Cost % is 0.00 as of Aug. 26, 2026. GuruFocus rates BKK:SKR-R with a GF Score™ of 90/100 and a GF Value™ of ฿8.11 (Fairly Valued). The stock has 5 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Sikarin PCL ranks better than 91.7% on this metric.

Sikarin PCL's yield on cost for the quarter that ended in Jun. 2026 was 0.00.


The historical rank and industry rank for Sikarin PCL's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Sikarin PCL's highest Yield on Cost was 9.32. The lowest was 1.55. And the median was 4.02.


BKK:SKR-R's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.96
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Sikarin PCL  (BKK:SKR-R) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Sikarin PCL 5-Year Yield-on-Cost % Related Terms


BKK:SKR-R vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison

For the Medical Care Facilities subindustry, Sikarin PCL's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sikarin PCL 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Sikarin PCL's 5-Year Yield-on-Cost % falls into.


BKK:SKR-R
90GF Score
Sikarin PCL BKK:SKR-R
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sikarin PCL 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Sikarin PCL is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Sikarin PCL (BKK:SKR-R) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 26, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sikarin PCL and its competitors. Over the past decade, Sikarin PCL's 5-Year Yield-on-Cost % has ranged from 1.55 to 9.32. According to the industry distribution chart, Sikarin PCL ranks #23 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 8.3%.
Is Sikarin PCL's 5-Year Yield-on-Cost % too high?
Sikarin PCL's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.55 to a high of 9.32. Based on the distribution chart, Sikarin PCL ranks #23 out of 277 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Sikarin PCL has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sikarin PCL's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sikarin PCL ranks #23 out of 277 companies for 5-Year Yield-on-Cost %. This places Sikarin PCL in the top 8% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.96. Historically, Sikarin PCL's own 5-Year Yield-on-Cost % has ranged from 1.55 to 9.32 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.96, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sikarin PCL and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sikarin PCL's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sikarin PCL stock overvalued right now?
Based on GuruFocus' analysis, Sikarin PCL (BKK:SKR-R) is currently considered Fairly Valued. The stock's GF Value™ is ฿8.11, compared to a current price of ฿7.85 — trading 3.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Sikarin PCL's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sikarin PCL (BKK:SKR-R), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sikarin PCL (BKK:SKR-R) Overvalued in 2026?

Based on GuruFocus' analysis, Sikarin PCL stock appears to be undervalued. The current stock price of ฿7.85 is trading 3.2% below its estimated GF Value™ of ฿8.11. GuruFocus considers Sikarin PCL to be Fairly Valued.

Key valuation signals for BKK:SKR-R:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: ฿8.11 vs. price of ฿7.85 (3.2% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the BKK:SKR-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sikarin PCL Business Description

Other Exchanges SKR:Thailand
Address 976, Lasalle Road, Bangna Tai Subdistrict, Bangna District, Bangkok, THA, 10260
SSikarin PCL provides general healthcare services and operates under the social security system. The Group has one main operating segment, which is providing healthcare services through private hospitals and hospitals affiliated with the social security system. The Group operates in a single geographical area, which is Thailand. Its services include medical centers, a pediatric center, a women's institute, a radiology center, a neurology center, a rehabilitation center, and an orthopedic center.
90GF Score

Get the complete analysis for BKK:SKR-R

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿7.85
Price
฿8.11
GF Value